http://www.amgen.com/monthly http://www.amgen.com/about/monthly http://www.amgen.com/about/quick-facts/monthly http://www.amgen.com/about/mission-and-values/monthly http://www.amgen.com/about/leadership/monthly http://www.amgen.com/about/awards-and-accolades/monthly http://www.amgen.com/about/how-we-operate/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/board-of-directors-guidelines-for-director-qualifications-and-evaluations/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/duties-and-responsibilities-of-the-lead-independent-director/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/board-of-directors-corporate-governance-principles/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/audit-committee/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/compensation-and-management-development-committee/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/corporate-responsibility-and-compliance-committee/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/equity-award-committee/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/governance-and-nominating-committee/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/board-of-directors-code-of-conduct/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/staff-code-of-conduct/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/supplier-code-of-conduct/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/code-of-ethics-for-ceo-and-senior-financial-officers/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/policy-on-executive-compensation-in-restatement-situations/monthly http://www.amgen.com/about/how-we-operate/corporate-governance/rights-plan-policy/monthly http://www.amgen.com/about/how-we-operate/business-ethics-and-compliance/monthly http://www.amgen.com/about/how-we-operate/business-ethics-and-compliance/annual-declaration-of-compliance/monthly http://www.amgen.com/about/how-we-operate/business-ethics-and-compliance/elements-of-an-effective-compliance-program/monthly http://www.amgen.com/about/how-we-operate/business-ethics-and-compliance/amgens-culture-of-compliance/monthly http://www.amgen.com/about/how-we-operate/business-ethics-and-compliance/staff-code-of-conduct/monthly http://www.amgen.com/about/how-we-operate/business-ethics-and-compliance/corporate-compliance-policies/monthly http://www.amgen.com/about/how-we-operate/business-ethics-and-compliance/reporting-a-concern/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/ethical-research/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/ethical-research/global-code-of-ethics-for-clinical-trials/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/ethical-research/clinical-data-transparency-practices/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/ethical-research/clinical-data-transparency-practices/clinical-trial-data-sharing-request/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/ethical-research/amgen-guidelines-for-publications/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/ethical-research/biobanking-of-human-samples/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/ethical-research/adverse-event-reporting/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/ethical-research/commitment-to-the-ethical-use-of-animals-in-research/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/ethical-research/amgen-statement-on-compendia/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/ethical-research/r-and-d-gifts-policy/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/responsible-marketing-and-product-information/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/responsible-marketing-and-product-information/direct-to-consumer-dtc-advertising/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/responsible-marketing-and-product-information/interactions-with-healthcare-providers/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/corporate-giving/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/business-conduct/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/business-conduct/quality/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/business-conduct/protection-of-personal-information/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/business-conduct/guidelines-for-protecting-social-security-numbers/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/business-conduct/insider-trading/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/business-conduct/conflicts-of-interest/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/business-conduct/antitrust-and-unfair-competition/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/business-conduct/dealing-with-the-government/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/business-conduct/political-activities/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/work-environment/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/work-environment/professional-conduct/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/work-environment/safe-and-healthy-workplace/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/work-environment/environment-health-and-safety/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/work-environment/equal-employment-opportunity/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/work-environment/non-discrimination-and-harassment-free-workplace/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/work-environment/compliance-reporting-and-non-retaliation/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/international-trade/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/international-trade/economic-sanctions-embargoes-and-boycotts/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/international-trade/anti-corruption-and-us-foreign-corrupt-practices/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/international-trade/export-and-import-control-laws/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/the-value-of-our-medicines/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/the-value-of-our-medicines/pricing/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/independent-medical-education-and-healthcare-donations/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/european-donations-to-patient-groups/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/european-donations-to-patient-groups/2008---amgen-europe-gmbh-and-affiliates-patient-donations/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/european-donations-to-patient-groups/2009---amgen-europe-gmbh-and-affiliates-patient-donations/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/european-donations-to-patient-groups/2010---amgen-europe-gmbh-and-affiliates-patient-donations/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/european-donations-to-patient-groups/2011---amgen-europe-gmbh-and-affiliates-patient-donations/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/european-donations-to-patient-groups/2012---amgen-europe-gmbh-and-affiliates-patient-donations/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/european-donations-to-patient-groups/2013---amgen-europe-gmbh-and-affiliates-patient-donations/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/european-donations-to-patient-groups/2014---amgen-europe-gmbh-and-affiliates-patient-donations/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/european-donations-to-patient-groups/2015---amgen-europe-gmbh-and-affiliates-patient-donations/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/european-donations-to-patient-groups/2016---amgen-europe-gmbh-and-affiliates-patient-donations/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/donation-and-grant-recipients/donations-and-grant-disclosures-faqs/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/political-contributions/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/transparency-disclosures/physician-payment-disclosures/monthly http://www.amgen.com/about/how-we-operate/policies-practices-and-disclosures/privacy-pledge-to-patients/monthly http://www.amgen.com/science/monthly http://www.amgen.com/science/research-and-development-strategy/monthly http://www.amgen.com/science/scientific-advisory-board/monthly http://www.amgen.com/science/clinical-trials/monthly http://www.amgen.com/science/clinical-trials/about-clinical-trials/monthly http://www.amgen.com/science/clinical-trials/information-for-healthcare-professionals/monthly http://www.amgen.com/science/clinical-trials/information-for-healthcare-professionals/research-philosophy/monthly http://www.amgen.com/science/clinical-trials/information-for-healthcare-professionals/investigator-resources/monthly http://www.amgen.com/science/clinical-trials/information-for-healthcare-professionals/investigator-survey/monthly http://www.amgen.com/science/clinical-trials/clinical-data-transparency-practices/monthly http://www.amgen.com/science/clinical-trials/clinical-data-transparency-practices/clinical-trial-data-sharing-request/monthly http://www.amgen.com/science/manufacturing/monthly http://www.amgen.com/products/monthly http://www.amgen.com/products/global-patient-safety/monthly http://www.amgen.com/products/global-patient-safety/adverse-event-reporting/monthly http://www.amgen.com/products/counterfeit-drug-statement/monthly http://www.amgen.com/products/safety-data-sheets/monthly http://www.amgen.com/responsibility/monthly http://www.amgen.com/responsibility/amgens-commitment-to-patients/monthly http://www.amgen.com/responsibility/responsibility-highlights-report/monthly http://www.amgen.com/responsibility/responsibility-stories/monthly http://www.amgen.com/responsibility/amgen-foundation/monthly http://www.amgen.com/responsibility/amgen-foundation/staff-involvement-programs/monthly http://www.amgen.com/responsibility/access-to-medicine/monthly http://www.amgen.com/responsibility/access-to-medicine/reimbursement-support-services-and-financial-assistance-programs/monthly http://www.amgen.com/responsibility/access-to-medicine/access-to-investigational-medicines/monthly http://www.amgen.com/responsibility/access-to-medicine/value-and-access/monthly http://www.amgen.com/responsibility/access-to-medicine/value-and-access/pricing/monthly http://www.amgen.com/responsibility/environmental-sustainability/monthly http://www.amgen.com/responsibility/environmental-sustainability/performance/monthly http://www.amgen.com/responsibility/environmental-sustainability/performance/carbon/monthly http://www.amgen.com/responsibility/environmental-sustainability/performance/water/monthly http://www.amgen.com/responsibility/environmental-sustainability/performance/waste/monthly http://www.amgen.com/responsibility/environmental-sustainability/performance/fuel-efficiency/monthly http://www.amgen.com/responsibility/environmental-sustainability/performance/targets/monthly http://www.amgen.com/responsibility/environmental-sustainability/performance/reporting/monthly http://www.amgen.com/responsibility/environmental-sustainability/performance/reporting/summary-of-data/monthly http://www.amgen.com/responsibility/environmental-sustainability/performance/reporting/cdp/monthly http://www.amgen.com/responsibility/environmental-sustainability/commitment/monthly http://www.amgen.com/responsibility/environmental-sustainability/sustainable-by-design/monthly http://www.amgen.com/responsibility/environmental-sustainability/sustainable-by-design/product-sustainability/monthly http://www.amgen.com/responsibility/environmental-sustainability/sustainable-by-design/green-buildings/monthly http://www.amgen.com/responsibility/environmental-sustainability/case-studies/monthly http://www.amgen.com/responsibility/environmental-sustainability/case-studies/neulasta-packaging-footprint-reduction/monthly http://www.amgen.com/responsibility/environmental-sustainability/case-studies/when-buildings-talk/monthly http://www.amgen.com/responsibility/environmental-sustainability/case-studies/green-chemistry-smart-science/monthly http://www.amgen.com/responsibility/environmental-sustainability/case-studies/small-change-leads-to-big-water-savings/monthly http://www.amgen.com/responsibility/supplier-sustainability/monthly http://www.amgen.com/responsibility/supplier-sustainability/california-supply-chain-transparency-act/monthly http://www.amgen.com/responsibility/grants-and-giving/monthly http://www.amgen.com/responsibility/grants-and-giving/amgen-foundation-grants/monthly http://www.amgen.com/responsibility/grants-and-giving/amgen-foundation-grants/amgen-foundation-grant-guidelines/monthly http://www.amgen.com/responsibility/grants-and-giving/amgen-foundation-grants/letter-of-inquiry-checklist/monthly http://www.amgen.com/responsibility/grants-and-giving/amgen-foundation-grants/grant-application-checklist/monthly http://www.amgen.com/responsibility/grants-and-giving/amgen-foundation-grants/amgen-foundation-grant-faqs/monthly http://www.amgen.com/responsibility/grants-and-giving/independent-medical-education-funding/monthly http://www.amgen.com/responsibility/grants-and-giving/independent-medical-education-funding/independent-medical-education-frequently-asked-questions/monthly http://www.amgen.com/responsibility/grants-and-giving/independent-medical-education-funding/budget-instructions/monthly http://www.amgen.com/responsibility/grants-and-giving/independent-medical-education-funding/contact-us/monthly http://www.amgen.com/responsibility/grants-and-giving/us-healthcare-donations/monthly http://www.amgen.com/responsibility/grants-and-giving/us-healthcare-donations/eligibility-criteria/monthly http://www.amgen.com/responsibility/grants-and-giving/us-healthcare-donations/healthcare-donations-frequently-asked-questions/monthly http://www.amgen.com/responsibility/grants-and-giving/us-healthcare-donations/contact-us/monthly http://www.amgen.com/responsibility/grants-and-giving/non-healthcare-donations-and-sponsorships/monthly http://www.amgen.com/responsibility/grants-and-giving/equipment-donations/monthly http://www.amgen.com/responsibility/responsibility-stories/monthly http://www.amgen.com/responsibility/safety-and-wellness/monthly http://www.amgen.com/responsibility/safety-and-wellness/safety/monthly http://www.amgen.com/responsibility/safety-and-wellness/wellness/monthly http://www.amgen.com/responsibility/reporting-and-metrics/monthly http://www.amgen.com/responsibility/reporting-and-metrics/gri-index/monthly http://www.amgen.com/responsibility/reporting-and-metrics/archived-reports/monthly http://www.amgen.com/annualmeeting/monthly http://www.amgen.com/media/monthly http://www.amgen.com/media/news-releases/monthly http://www.amgen.com/media/featured-news/monthly http://www.amgen.com/media/our-perspective/monthly http://www.amgen.com/media/our-perspective/amgen-response-to-icers-draft-scoping-document-on-car-t-therapy-for-b-cell-cancers/monthly http://www.amgen.com/media/our-perspective/amgens-position-on-orphan-drugs-and-icers-orphan-drug-assessment/monthly http://www.amgen.com/media/our-perspective/amgen-response-to-the-icer-draft-report-on-anabolic-therapies-for-osteoporosis/monthly http://www.amgen.com/media/our-perspective/amgen-response-to-icer-updated-value-assessment-framework/monthly http://www.amgen.com/media/our-perspective/amgen-statement-and-response-to-icer-revised-value-framework/monthly http://www.amgen.com/media/our-perspective/amgen-statement-on-appeals-court-decision-on-pcsk9-antibody-patents/monthly http://www.amgen.com/media/our-perspective/amgen-reponse-to-hta-program-draft-evidence-report-on-the-treatment-of-chronic-migraines/monthly http://www.amgen.com/media/our-perspective/amgen-introduces-new-value-based-pharmacy-benefits-insurance-provision-for-u-s--staff-members/monthly http://www.amgen.com/media/our-perspective/amgen-response-to-icer-plaque-psoriasis-draft-evidence-report/monthly http://www.amgen.com/media/our-perspective/amgen-response-to-icer-rheumatoid-arthritis-draft-evidence-report/monthly http://www.amgen.com/media/our-perspective/amgen-response-to-icers-call-for-comments-on-its-value-assessment-framework/monthly http://www.amgen.com/media/our-perspective/amgen-response-to-icers-proposed-adaptation-of-the-icer-value-framework/monthly http://www.amgen.com/media/our-perspective/amgen-statement-on-the-clinical-and-economic-value-of-blincyto/monthly http://www.amgen.com/media/our-perspective/archives/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/response-to-icers-background-and-draft-scoping-document-disease-modifying-anti-rheumatic-drugs/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-regarding-pcsk9-economic-analysis-published-in-jama/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-regarding-pcsk9-economic-analysis-published-in-jama/letters-to-the-editors/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-regarding-pcsk9-economic-analysis-published-in-jama/letters-to-the-editors/cost-effectiveness-model-greatly-exaggerates-costs-of-pcsk9-inhibitors/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-regarding-pcsk9-economic-analysis-published-in-jama/letters-to-the-editors/jama-report-on-cholesterol-drugs-fails-reliability-test-by-raymond-c--jordan/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-regarding-pcsk9-economic-analysis-published-in-jama/letters-to-the-editors/flawed-jama-study-misrepresents-costs-and-benefits-of-new-cholesterol-drugs/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-regarding-pcsk9-economic-analysis-published-in-jama/letters-to-the-editors/usa-today-new-cholesterol-drugs-could-add-$120-billion-to-annual-u-s--health-costs/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-response-to-the-proposed-icer-review-of-treatments-for-ra-and-psa/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/response-to-icers-background-and-draft-scoping-document-treatment-options-for-plaque-psoriasis/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgens-response-to-technology-assessments-for-kyprolis-carfilzomib-in-multiple-myeloma/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgens-response-to-icers-draft-report-treatment-options-for-relapsed-or-refractory-multiple-myeloma/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgens-response-to-technology-assessments-for-kyprolis-carfilzomib-in-multiple-myeloma/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-response-to-usa-today-article-on-restructuring/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-on-ema-review-of-ivabradine/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-on-fda-fast-track-designation-for-investigational-ivabradine/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/commercialize-prolia-on-its-own-in-the-european-union-switzerland-norway-russia-and-mexico/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-on-evolocumab-proactive-monitoring/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-on-jan-27-2014-fda-warning-letter/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-on-support-for-sound-science-based-biosimilar-policies/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-submits-comments-to-fda-on-biosimilars-naming-citizen-petitions/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-supports-distinguishable-naming-policy-for-biosimilars/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-on-veto-for-california-biosimilars-bill/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-on-gpha-citizen-petition-on-naming-for-biologics/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-response-to-the-new-england-journal-of-medicine-study/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/neulasta-and-the-340b-drug-discount-program/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-welcomes-european-commission-report-on-eu-biosimilars-uptake/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-on-additional-biomarker-analysis-beyond-kras-from-completed-phase-3-study/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/response-to-the-editorial-building-a-wall-against-biosimilars-nature-biotechnology/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-supports-world-health-organizations-proposed-distinguishable-naming-policy-for-biosimilars/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-response-to-recent-new-york-times-story-biotech-firms-billions/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-response-to-recent-new-york-times-stories-and-an-editorial/monthly http://www.amgen.com/media/our-perspective/archives/statements-and-responses/amgen-statement-on-stroke-research/monthly http://www.amgen.com/media/our-perspective/archives/opinion-pieces/aug-25-2016---submitted-to-the-jama-editor/monthly http://www.amgen.com/media/our-perspective/archives/opinion-pieces/mar-18-2013---submitted-to-the-editor---los-angeles-times/monthly http://www.amgen.com/media/our-perspective/archives/opinion-pieces/feb-13-2013---submitted-to-the-editor---denver-post/monthly http://www.amgen.com/media/our-perspective/archives/opinion-pieces/feb-12-2013---submitted-to-the-editor---new-york-times/monthly http://www.amgen.com/media/our-perspective/archives/opinion-pieces/jan-29--2013---submitted-to-the-editor---new-york-times/monthly http://www.amgen.com/media/our-perspective/archives/opinion-pieces/jan-28-2013---submitted-to-the-editor---new-york-times/monthly http://www.amgen.com/media/media-contacts/monthly http://www.amgen.com/partners/monthly http://www.amgen.com/partners/academic-collaborations/monthly http://www.amgen.com/partners/academic-collaborations/new-requests/monthly http://www.amgen.com/partners/academic-collaborations/new-requests/australia/monthly http://www.amgen.com/partners/academic-collaborations/requests-for-refill-or-amendment/monthly http://www.amgen.com/partners/academic-collaborations/requests-for-refill-or-amendment/australia/monthly http://www.amgen.com/partners/academic-collaborations/scientific-report-or-notice-of-invention/monthly http://www.amgen.com/partners/suppliers/monthly http://www.amgen.com/partners/suppliers/supplier-diversity/monthly http://www.amgen.com/partners/suppliers/supplier-diversity/amgens-statement-on-supplier-diversity/monthly http://www.amgen.com/partners/suppliers/supplier-diversity/supplier-diversity-program-at-amgen/monthly http://www.amgen.com/partners/suppliers/supplier-diversity/our-commitment/monthly http://www.amgen.com/partners/suppliers/supplier-diversity/registering-with-amgen/monthly http://www.amgen.com/partners/suppliers/supplier-diversity/amgens-sourcing-categories/monthly http://www.amgen.com/partners/suppliers/supplier-diversity/affiliations/monthly http://www.amgen.com/partners/suppliers/supplier-resources/monthly http://www.amgen.com/partners/suppliers/supplier-resources/supplier-procurement-guidelines/monthly http://www.amgen.com/partners/suppliers/supplier-resources/supplier-code-of-conduct/monthly http://www.amgen.com/partners/suppliers/supplier-resources/conflict-minerals-policy/monthly http://www.amgen.com/partners/suppliers/supplier-resources/supplier-invoice-guidelines/monthly http://www.amgen.com/partners/suppliers/supplier-resources/supplier-shipping-and-receiving/monthly http://www.amgen.com/partners/suppliers/supplier-resources/supplier-contact-information/monthly http://www.amgen.com/partners/suppliers/supplier-resources/existing-supplier-on-boarding/monthly http://www.amgen.com/partners/suppliers/supplier-resources/supplier-terms-and-conditions/monthly http://www.amgen.com/partners/wholesalers/monthly http://www.amgen.com/search/monthly http://www.amgen.com/bcr/monthly http://www.amgen.com/privacy-statement/monthly http://www.amgen.com/safe-harbor-policy-statement/monthly http://www.amgen.com/terms-of-use/monthly http://www.amgen.com/contact-us/monthly http://www.amgen.com/contact-us/product-inquiries/monthly http://www.amgen.com/contact-us/contact-us-feedback/monthly